Find your next paid study

University of OklahomaNCT06660017

~$75 – $2,000

Actual pay is set by the research site.

Carolina Senior: UNC Registry for Older Cancer Patients

RATIONALE: Gathering information about older patients with cancer may help the study of cancer in the future. PURPOSE: This research study is gathering inform…

Chronic Myeloproliferative DisordersCognitive/Functional EffectsLeukemia+6 more

UNC Lineberger Comprehensive Cancer CenterNCT01137825

~$10 – $750

Actual pay is set by the research site.

Observational

Telehealth Music Therapy for Adults With Endocrine System Based Autoimmune Disease and a Depressive Disorder: An Intervention Development Study

The goal of this clinical trial is to explore if a telehealth music therapy intervention helps with quality of life, depression symptoms, anxiety symptoms. It …

Type 1 DiabetesHashimoto DiseaseGraves Disease+4 more

Appalachian State UniversityNCT07413874

~$10 – $750

Actual pay is set by the research site.

Colorectal NeoplasmsCarcinoma, Non-Small-Cell LungStomach Neoplasms+3 more

An Open-label Phase 1 Study to Investigate PF-08046050 (SGN-CEACAM5C) in Adults With Advanced Solid Tumors

This clinical trial is studying advanced solid tumors. Solid tumors are cancers that start in a part of your body like your lungs or liver instead of your bloo…

Seagen, a wholly owned subsidiary of PfizerNCT06131840

Actual pay is set by the research site.

Phase 2

Single- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral Metastases

Spine radiosurgery (SRS) utilizes advanced treatment planning with focused x-rays to deliver one to four high dose treatments to the spine to help relieve pain…

Spine MetastasesSpine Stereotactic Radiosurgery (sSRS)

Case Comprehensive Cancer CenterNCT04218617

~$75 – $2,000

Actual pay is set by the research site.

Advanced-stage Solid Tumors

A Phase 1 Study of JNJ-89862175, an Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 3 Antibody Drug Conjugate, for Advanced Solid Tumors

The purpose of this study is to determine safe and effective dose (recommended phase 2 doses \[RP2Ds\]) of JNJ-89862175 in Part 1 (dose escalation), and to fur…

Janssen Research & Development, LLCNCT07223125

Actual pay is set by the research site.

Mesothelin-Expressing TumorsEpithelial Ovarian CancerMalignant Pleural Mesothelioma, Advanced+8 more

Phase 1a/1b Study of CT-95 in Advanced Cancers Associated With Mesothelin Expression

This is a Phase 1a/1b, first-in-human (FIH), open-label, multi-center dose escalation and expansion study of the safety, pharmacokinetics (PK), pharmacodynamic…

Context Therapeutics Inc.NCT06756035

Actual pay is set by the research site.

A Prospective Analysis of the Efficacy of Allosync Expand and Autograft Bone Graft in Open Lumbar Spinal Fusion

The purpose of this study is to assess the radiographic and clinical outcomes of spinal fusion following use of Allosync Expand and autograft bone graft.

Spondylolisthesis, Grade 1

Research SourceNCT06415110

~$10 – $1,125

Actual pay is set by the research site.

Glioblastoma Multiforme (GBM)Pancreatic Ductal Adenocarcinoma (PDAC)

Dosimetry and Bio-distribution of 203Pb-RMX-VH-PIB in Newly Diagnosed or Recurrent Patients With Solid Tumors: A Phase I Exploratory Study

The goal of this Phase I clinical trial is to evaluate how the imaging drug 203Pb- RMX-VH-PIB distributes in the body and how much radiation different organs r…

Radiomedix, Inc.NCT07733674

Actual pay is set by the research site.

Phase 1/2 Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

The primary goal of this study is to assess the safety and tolerability of mRNA-4359 administered alone and in combination with pembrolizumab or ipilimumab and…

Advanced Solid Tumors

ModernaTX, Inc.NCT05533697

Actual pay is set by the research site.

NSCLC (Advanced Non-small Cell Lung Cancer)HNSCCCRC (Colorectal Cancer)+4 more

A Phase 1, First in Human, Open-Label Multicenter Study to Evaluate ALX2004, an Antibody Drug Conjugate Targeting EGFR in Participants With Advanced or Metastatic Select Solid Tumors

A Phase 1, First in Human, Open-Label Multicenter Study to Evaluate ALX2004, an Antibody Drug Conjugate Targeting EGFR in Participants with Advanced or Metasta…

ALX Oncology Inc.NCT07085091

Actual pay is set by the research site.

Phase 3

A Phase 3, Multicenter, Randomized, Open-label, Study Evaluating the Efficacy and Safety of Nanvuranlat in Patients With Previously Treated Advanced Biliary Tract Cancer

This study is designed to 1) select a dose regimen for continued development and 2) evaluate nanvuranlat versus Physicians Best Choice (PBC) (FOLFOX, FOLFIRI, …

Advanced Biliary Tract CancerBiliary Tract Cancer (BTC)